1,106
Participants
Start Date
January 24, 2007
Primary Completion Date
March 7, 2008
Study Completion Date
May 14, 2012
GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM)
Three doses administered intramuscularly at months 0, 1 and 6
Gardasil ® (Merck & Co. Inc)
Three doses administered intramuscularly at months 0, 2 and 6
Placebo
One dose administered intramuscularly at month 1 to maintain blinding
Placebo
One dose administered intramuscularly at month 2 to maintain blinding
GSK Investigational Site, New York
GSK Investigational Site, The Bronx
GSK Investigational Site, Carnegie
GSK Investigational Site, Upper Saint Clair
GSK Investigational Site, Erie
GSK Investigational Site, Erie
GSK Investigational Site, Lancaster
GSK Investigational Site, Philadelphia
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Atlanta
GSK Investigational Site, Coral Gables
GSK Investigational Site, Miami
GSK Investigational Site, Boynton Beach
GSK Investigational Site, Bardstown
GSK Investigational Site, Willoughby Hills
GSK Investigational Site, Cleveland
GSK Investigational Site, Cincinnati
GSK Investigational Site, Stevensville
GSK Investigational Site, Saint Paul
GSK Investigational Site, Chaska
GSK Investigational Site, Arkansas City
GSK Investigational Site, Wichita
GSK Investigational Site, Omaha
GSK Investigational Site, Fort Worth
GSK Investigational Site, Houston
GSK Investigational Site, Austin
GSK Investigational Site, Louisville
GSK Investigational Site, Aurora
GSK Investigational Site, Boise
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Chandler
GSK Investigational Site, West Covina
GSK Investigational Site, Vista
GSK Investigational Site, San Diego
GSK Investigational Site, San Francisco
GSK Investigational Site, Tacoma
GSK Investigational Site, Wenatchee
GSK Investigational Site, Walla Walla
GSK Investigational Site, Milford
GSK Investigational Site, Warwick
Lead Sponsor
GlaxoSmithKline
INDUSTRY